TORONTO, ONTARIO / ACCESSWIRE / October 24, 2014 / Allegiance Equity Corporation ("ANQ") (TSX VENTURE: ANQ.V) confirms the re-scheduling of an annual and special meeting of its shareholders (the "Meeting" ) for November 18, 2014 at 10:00 AM in the morning (Toronto time) to be held at the Marriott Courtyard Hotel, The Leaside Room, 475 Yonge Street, Toronto, Ontario. The Meeting was previously scheduled for October 20, 2014.
Additional details about the Meeting are filed under ANQ's profile at www.sedar.com.
About ANQ
ANQ is an Ontario corporation that has developed unique standardized mass-market nutraceutical products for the treatment of common ailments where present pharmaceutical treatments and Over the Counter (OTC) products fail to meet the needs of patients. ANQ has targeted markets having clearly identified product deficiencies and dissatisfied consumers afflicted with common conditions including memory loss, dementia, high blood glucose and inflammatory skin conditions. ANQ obtains regulatory approval and patents for these unique compounds and formulations and has licensed and proposes to license its products for royalty revenues.
Cautionary Statement Regarding Forward-Looking Information
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements in this news release include, but are not limited to, ANQ's objectives and intentions. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; delay or failure to receive board, shareholder or regulatory approvals; those additional risks set out in ANQ's public documents filed on SEDAR at www.sedar.com; and other matters discussed in this news release. Although ANQ believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by law, ANQ disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the Policies of the Exchange) accepts responsibility of the adequacy or accuracy of this release.
For further information please contact:
Marilyn Bloovol, President and CEO, Allegiance Equity Corporation
[email protected]
(416) 489-5928
SOURCE: Allegiance Equity Corporation